Skip to main content
. 2015 Dec 16;11(2):631–636. doi: 10.3892/etm.2015.2939

Figure 1.

Figure 1.

Immunohistochemical staining of C/EBPα in (A) healthy control skin samples and (B) psoriatic lesions. Magnification, ×100. (C) Expression levels of C/EBPα in psoriatic lesions and healthy control skin samples, as determined from the grey value, where higher grey values indicate lower expression levels.*P<0.01 vs. healthy controls. C/EBP, CCATT/enhancer binding protein.